Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-VEGFR3/FLT4 Antibody (7C228)
😃Good
Catalog No. TMAY-03365
Alias VEGFR-3, VEGFR3, VEGF Receptor 3, PCL, LMPH1A, fms related tyrosine kinase 4, FLT-41, FLT41, FLT-4
Anti-VEGFR3/FLT4 Antibody (7C228) is a Rabbit antibody targeting VEGFR3/FLT4. Anti-VEGFR3/FLT4 Antibody (7C228) can be used in ELISA.
Anti-VEGFR3/FLT4 Antibody (7C228)
Anti-VEGFR3/FLT4 Antibody (7C228)
😃Good
Catalog No. TMAY-03365Alias VEGFR-3, VEGFR3, VEGF Receptor 3, PCL, LMPH1A, fms related tyrosine kinase 4, FLT-41, FLT41, FLT-4
Anti-VEGFR3/FLT4 Antibody (7C228) is a Rabbit antibody targeting VEGFR3/FLT4. Anti-VEGFR3/FLT4 Antibody (7C228) can be used in ELISA.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 100 μL | $269 | 7-10 days |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Antibody Type: Rabbit Monoclonal Application: ELISA Reactivity: Mouse |
| Alias | VEGFR-3, VEGFR3, VEGF Receptor 3, PCL, LMPH1A, fms related tyrosine kinase 4, FLT-41, FLT41, FLT-4 |
| Ig Type | Rabbit IgG |
| Clone | 7C228 |
| Reactivity | Mouse |
| Application | ELISA |
| Recommended Dose | ELISA: 1:5000-1:10000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Mouse VEGFR3 / FLT-4 (rM VEGFR3 / FLT-4; TMPY-01936; P35917-1; Met1-Glu775). |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | Vascular endothelial growth factor receptor 3 (VEGFR3), also known as FLT-4, together with the other two members VEGFR1 (FLT-1) and VEGFR2 (KDR/Flk-1) are receptors for vascular endothelial growth factors (VEGF) and belong to the class III subfamily of receptor tyrosine kinases (RTKs). The VEGFR3 protein is expressed mainly on lymphatic vessels but it is also up-regulated in tumor angiogenesis. Mutations in VEGFR3 have been identified in patients with primary lymphoedema. The VEGF-C/VEGF-D/VEGFR3 signaling pathway may provide a target for antilymphangiogenic therapy in prostate cancer, breast cancer, gastric cancer, lung cancer, non-small cell lung cancer (NSCLC), and so on.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Mouse VEGFR3 / FLT-4 protein (TMPY-01936) |
| Antigen Species | Mouse |
| Biology Area | Cancer Drug Targets, Receptor Tyrosine Kinases (RTKs) |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-VEGFR3/FLT4 Antibody (7C228) | purchase Anti-VEGFR3/FLT4 Antibody (7C228) | Anti-VEGFR3/FLT4 Antibody (7C228) cost | order Anti-VEGFR3/FLT4 Antibody (7C228)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.